Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer

To compare the effectiveness and safety of chemoradiotherapy plus surgery with that of chemoradiotherapy alone in people with nonmetastatic esophageal carcinoma in terms of OS, progression-free survival (PFS), quality–of-life (QoL), treatment-related mortality and morbidity.

This is a protocol.

Share/Save